Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 10.516% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Nc1cc(=O)[nH]c(SCC(=O)N2N=C(c3ccc4ccccc4c3)CC2c2ccccc2)n1
b.) N/C(COc1ncn(-c2ccccc2)n1)=N\S(=O)(=O)c1ccc(Cl)cc1Cl
c.) CC(C)(C)SCCNC(=O)c1cccc([N+](=O)[O-])c1
Answer: c. CC(C)(C)SCCNC(=O)c1cccc([N+](=O)[O-])c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)SCCNC(=O)c1cccc([N+](=O)[O-])c1
CC(C)(C)SCCNC(=O)c1cccc([N+](=O)[O-])c1
N-(2-tert-butylsulfanylethyl)-3-nitrobenzamide